NCT00637195 2020-01-03Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)GlaxoSmithKlinePhase 3 Completed152 enrolled 21 charts
NCT00534638 2019-11-15Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy AdolescentsGlaxoSmithKlinePhase 4 Completed34,412 enrolled 21 charts
NCT00652938 2018-08-17Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female SubjectsGlaxoSmithKlinePhase 3 Completed744 enrolled 27 charts